The NDEWS Coordinating Center thought you should be aware of a new mandate from the DEA decreasing the amount of Schedule II opiate and opioid medications such as oxycodone, hydrocodone, fentanyl, hydromorphone, morphine, to be manufactured in 2017. Below are links to the DEA press release and the Final Order published in the Federal Register.